CSIRO partners with Cicada to translate ‘superbug’ research

  17 November 2021

The national science agency has partnered with a deep tech incubator to try and build out a local industry for antimicrobial resistance products, warning the pipeline for new “superbug” treatments is running dry.

CSIRO and Sydney deep tech incubator Cicada Innovations will offer local SMEs and researchers free training to commercialise their work into solutions for antimicrobial resistance (AMR), the emerging global public health threat where disease causing germs stop responding to medicine.

Further reading: CSIRO
Author(s): Joseph Brookes
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!